Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 583

1.

A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.

Cladder-Micus MB, Vrijsen JN, Becker ES, Donders R, Spijker J, Speckens AE.

BMC Psychiatry. 2015 Nov 9;15:275. doi: 10.1186/s12888-015-0647-y.

2.

Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors.

Haq AU, Sitzmann AF, Goldman ML, Maixner DF, Mickey BJ.

J Clin Psychiatry. 2015 Oct;76(10):1374-84. doi: 10.4088/JCP.14r09528.

PMID:
26528644
3.

Psychosocial aspects of resistance in complex treatment of depressive disorder.

Sedlackova Z, Prasko J, Latalova K, Kamaradova D, Ociskova M, Grambal A, Sigmundova Z, Kasalova P, Cakirpaloglu S.

Neuro Endocrinol Lett. 2015;36(4):354-62.

PMID:
26454491
4.

Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.

Lenze EJ, Mulsant BH, Blumberger DM, Karp JF, Newcomer JW, Anderson SJ, Dew MA, Butters MA, Stack JA, Begley AE, Reynolds CF 3rd.

Lancet. 2015 Dec 12;386(10011):2404-12. doi: 10.1016/S0140-6736(15)00308-6. Epub 2015 Sep 27. Erratum in: Lancet. 2015 Dec 12;386(10011):2394.

PMID:
26423182
5.

The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A Study.

Fisher LB, Fava M, Doros GD, Alpert JE, Henry M, Huz I, Freeman MP.

J Nerv Ment Dis. 2015 Oct;203(10):762-8. doi: 10.1097/NMD.0000000000000364.

PMID:
26348584
6.

Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study.

Thase ME, Youakim JM, Skuban A, Hobart M, Zhang P, McQuade RD, Nyilas M, Carson WH, Sanchez R, Eriksson H.

J Clin Psychiatry. 2015 Sep;76(9):1232-40. doi: 10.4088/JCP.14m09689.

7.

Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants.

Thase ME, Youakim JM, Skuban A, Hobart M, Augustine C, Zhang P, McQuade RD, Carson WH, Nyilas M, Sanchez R, Eriksson H.

J Clin Psychiatry. 2015 Sep;76(9):1224-31. doi: 10.4088/JCP.14m09688.

8.

Ketamine-induced affective switch in a patient with treatment-resistant depression.

Banwari G, Desai P, Patidar P.

Indian J Pharmacol. 2015 Jul-Aug;47(4):454-5. doi: 10.4103/0253-7613.161277.

9.

Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.

Allen AP, Naughton M, Dowling J, Walsh A, Ismail F, Shorten G, Scott L, McLoughlin DM, Cryan JF, Dinan TG, Clarke G.

J Affect Disord. 2015 Nov 1;186:306-11. doi: 10.1016/j.jad.2015.06.033. Epub 2015 Jul 29.

PMID:
26275358
10.

The role of GRIK4 gene in treatment-resistant depression.

Milanesi E, Bonvicini C, Congiu C, Bortolomasi M, Gainelli G, Gennarelli M, Minelli A.

Genet Res (Camb). 2015 Jul 3;97:e14. doi: 10.1017/S0016672315000142.

PMID:
26139080
11.

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.

Xu AJ, Niciu MJ, Lundin NB, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Machado-Vieira R, Zarate CA Jr.

Neural Plast. 2015;2015:858251. doi: 10.1155/2015/858251. Epub 2015 Jun 7.

12.

Adjunctive Antipsychotic Prescriptions for Outpatients with Depressive Disorders in Asia: The Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD) Study.

Park SC, Shinfuku N, Maramis MM, Lee MS, Park YC.

Am J Psychiatry. 2015 Jul;172(7):684-5. doi: 10.1176/appi.ajp.2015.14121590. No abstract available.

PMID:
26130203
13.

Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms.

Olivares JM, Álvarez E, Carrasco JL, Pérez Páramo M, López-Gómez V.

Int Clin Psychopharmacol. 2015 Sep;30(5):265-71. doi: 10.1097/YIC.0000000000000087.

PMID:
26111356
14.

MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder.

Gabriela Nielsen M, Congiu C, Bortolomasi M, Bonvicini C, Bignotti S, Abate M, Milanesi E, Conca A, Cattane N, Tessari E, Gennarelli M, Minelli A.

J Affect Disord. 2015 Sep 1;183:179-86. doi: 10.1016/j.jad.2015.05.003. Epub 2015 May 11.

PMID:
26021967
15.
16.

Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis.

Zhou X, Ravindran AV, Qin B, Del Giovane C, Li Q, Bauer M, Liu Y, Fang Y, da Silva T, Zhang Y, Fang L, Wang X, Xie P.

J Clin Psychiatry. 2015 Apr;76(4):e487-98. doi: 10.4088/JCP.14r09204.

PMID:
25919841
17.

Less is more--possible option in the treatment of depression.

Dadić-Hero E, Knez R, Rebić J.

Coll Antropol. 2014 Dec;38(4):1207-9.

PMID:
25842759
18.

A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant Depression.

Phillips JL, Batten LA, Tremblay P, Aldosary F, Blier P.

Int J Neuropsychopharmacol. 2015 Mar 30;18(8). pii: pyv037. doi: 10.1093/ijnp/pyv037.

19.

Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.

Ball SG, Atkinson S, Sparks J, Bangs M, Goldberger C, Dubé S.

J Clin Psychopharmacol. 2015 Jun;35(3):266-72. doi: 10.1097/JCP.0000000000000302.

PMID:
25815754
20.

Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group.

Sühs KW, Correll C, Eberlein CK, Pul R, Frieling H, Bleich S, Kahl KG.

Brain Behav. 2015 Apr;5(4):e00318. doi: 10.1002/brb3.318. Epub 2015 Feb 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk